Identity
- Trade Name
- Alinity FDA UDI
- Generic Name
- Amikacin therapeutic drug monitoring IVD, kit, nephelometry/turbidimetry FDA UDI
- Device Name
- Alinity c Amikacin Reagent Kit 200 Tests FDA UDI
- Model / Reference
- 09P4420 FDA UDI
- Description
- Alinity c Amikacin Reagent Kit 200 Tests FDA UDI
Identifiers
- Catalog Number
- 09P4420 FDA UDI
- Primary DI / UDI-DI
- 00380740154103 FDA UDI
- 510(k) Number
- K052815 FDA UDI
- FDA Product Code
- KLQ FDA UDI
- GMDN Term
- Amikacin therapeutic drug monitoring IVD, kit, nephelometry/turbidimetry FDA UDI
Classification
- Device Class
- Class II FDA UDI
- Regulation Number
- 862.3035 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
No
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
Yes
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
Yes
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
No
FDA UDI
Lot / Batch Number
Yes
FDA UDI
Serial Number
No
FDA UDI
Expiration Date
Yes
FDA UDI
Manufacturing Date
No
FDA UDI
Category: Amikacin therapeutic drug monitoring IVD, kit, nephelometry/turbidimetry
Alinity by Abbott Laboratories, Inc. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Amikacin therapeutic drug monitoring IVD, kit, nephelometry/turbidimetry.
- ONLINE TDM Amikacin — Roche Diagnostics Corp. · Class II
- ARCHITECT — Abbott Laboratories, Inc. · Class II
Cleared under the same submission
K052815 also covers:
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class II | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Abbott Laboratories, Inc.
Sources (1)
- FDA UDI 05708912-45c3-4abc-8d58-8533b3a14b64 37 fields · synced May 31, 2026